Society guideline links: Diagnosis and treatment of Cushing's syndrome

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Adrenal cancer" and "Society guideline links: Adrenal incidentaloma".)

International

●Pituitary Society (PS): Consensus on diagnosis and management of Cushing's disease – A guideline update (2021)

●Endocrine Society (ES): Clinical practice guideline for treatment of Cushing's syndrome (2015)

●ES: Clinical practice guideline for the diagnosis of Cushing's syndrome (2008)

United States

●Choosing Wisely: Do not use serum cortisol levels as initial screening for adrenal hyperfunction [Cushing syndrome], instead consider superior strategies provided in the justification (2021)

●Clinical management of patients with Cushing syndrome treated with mifepristone – Consensus recommendations (2020)

Europe

●European Society of Endocrinology (ESE) and European Network for the Study of Adrenal Tumors (ENSAT): Clinical practice guideline for the management of adrenal incidentalomas (2016)

Japan

●Japan Endocrine Society (JES): New diagnostic criteria of adrenal subclinical Cushing's syndrome – Opinion (2018)